“The gender, age, race, and ethnic origin of a patient may play a role in how treatment may work or even how safe it may be,” explains Kate Owen, Senior Vice President of Global Clinical Operations at Bristol-Myers Squibb.
Understanding the importance of diversity in clinical trials in order to find treatments that are effective for all people, BMS has utilized various approaches such as online study search tools and other Internet-based methods to attract more diverse groups of people to trials. To read more, please visit ciscrp.org/wp-content/uploa...
Cabozantinib Clinical Trial
stem cell
